Literature DB >> 33545431

The relationship between cannabis use and cognition in people with bipolar disorder: A systematic scoping review.

T Jordan Walter1, Nina Pocuca2, Jared W Young3, Mark A Geyer3, Arpi Minassian4, William Perry2.   

Abstract

Bipolar disorder (BD) and cannabis use are highly comorbid and are each associated with cognitive impairment.  Given the prevalence of cannabis use in people with BD, it is important to understand whether the two interact to impact cognitive function. We performed a systematic scoping review to determine what is currently known in this field. We systematically searched PubMed, Embase, CINAHL, Web of Science, and PsycINFO for studies on the relationship between cannabis use and cognition in people with BD or relevant animal models. Six observational human studies and no animal studies met inclusion criteria. Two studies found cannabis use in BD was associated with better performance in some cognitive domains, while three studies found no association. One study found cannabis use in BD was associated with worse overall cognition. Overall, most identified studies suggest cannabis use is not associated with significant cognitive impairment in BD; however, the scope of knowledge in this field is limited, and more systematic studies are clearly required. Future studies should focus on longitudinal and experimental trials, and well-controlled observational studies with rigorous quantification of the onset, frequency, quantity, duration, and type of cannabis use, as well as BD illness features.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Bipolar disorder; Cannabis; Cognition

Mesh:

Year:  2020        PMID: 33545431      PMCID: PMC7914198          DOI: 10.1016/j.psychres.2020.113695

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  49 in total

1.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  Ann Intern Med       Date:  2009-07-20       Impact factor: 25.391

2.  Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania.

Authors:  Stephen M Strakowski; Melissa P DelBello; David E Fleck; Caleb M Adler; Robert M Anthenelli; Paul E Keck; Lesley M Arnold; Jennifer Amicone
Journal:  Arch Gen Psychiatry       Date:  2007-01

3.  Compared to high and low cannabis use, moderate use is associated with fewer cognitive deficits in psychosis.

Authors:  Ashley M Schnakenberg Martin; Kelsey A Bonfils; Beshaun J Davis; Elizabeth A Smith; Kelly Schuder; Paul H Lysaker
Journal:  Schizophr Res Cogn       Date:  2016-10-10

4.  Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans.

Authors:  E L Theunissen; P Heckman; E B de Sousa Fernandes Perna; K P C Kuypers; A Sambeth; A Blokland; J Prickaerts; S W Toennes; J G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2014-07-08       Impact factor: 4.530

5.  A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state.

Authors:  Matthew M Kurtz; Raphael T Gerraty
Journal:  Neuropsychology       Date:  2009-09       Impact factor: 3.295

6.  The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research.

Authors:  L Grinspoon; J B Bakalar
Journal:  J Psychoactive Drugs       Date:  1998 Apr-Jun

7.  Neurocognitive consequences of chronic cannabis use: a systematic review and meta-analysis.

Authors:  Pedro Rafael Figueiredo; Serenella Tolomeo; J Douglas Steele; Alexander Baldacchino
Journal:  Neurosci Biobehav Rev       Date:  2019-11-09       Impact factor: 8.989

Review 8.  Marijuana matters: reviewing the impact of marijuana on cognition, brain structure and function, & exploring policy implications and barriers to research.

Authors:  Kelly A Sagar; Staci A Gruber
Journal:  Int Rev Psychiatry       Date:  2018-07-03

9.  C-reactive protein is associated with cognitive performance in a large cohort of euthymic patients with bipolar disorder.

Authors:  C E Millett; M Perez-Rodriguez; M Shanahan; E Larsen; H S Yamamoto; C Bukowski; R Fichorova; K E Burdick
Journal:  Mol Psychiatry       Date:  2019-11-19       Impact factor: 15.992

Review 10.  Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations
.

Authors:  Amanda McCleery; Keith H Nuechterlein
Journal:  Dialogues Clin Neurosci       Date:  2019-09       Impact factor: 5.986

View more
  1 in total

Review 1.  Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence.

Authors:  Lauren Kuhns; Emese Kroon; Karis Colyer-Patel; Janna Cousijn
Journal:  Psychopharmacology (Berl)       Date:  2021-11-06       Impact factor: 4.415

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.